These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Combined antiviral-antimediator treatment for the common cold. Gwaltney JM; Winther B; Patrie JT; Hendley JO J Infect Dis; 2002 Jul; 186(2):147-54. PubMed ID: 12134249 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Sperber SJ; Sorrentino JV; Riker DK; Hayden FG Bull N Y Acad Med; 1989 Jan; 65(1):145-60. PubMed ID: 2557947 [TBL] [Abstract][Full Text] [Related]
6. Effects of dietary supplementation with conjugated linoleic acid on experimental human rhinovirus infection and illness. Peterson KM; O'Shea M; Stam W; Mohede IC; Patrie JT; Hayden FG Antivir Ther; 2009; 14(1):33-43. PubMed ID: 19320235 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. Gwaltney JM; Druce HM Clin Infect Dis; 1997 Nov; 25(5):1188-94. PubMed ID: 9402380 [TBL] [Abstract][Full Text] [Related]
8. Literature review: the common cold. Hilding DA Ear Nose Throat J; 1994 Sep; 73(9):639-43, 46-7. PubMed ID: 7988393 [TBL] [Abstract][Full Text] [Related]
9. Decreased rhinovirus shedding after intranasal oxymetazoline application in adults with induced colds compared with intranasal saline. Winther B; Buchert D; Turner RB; Hendley JO; Tschaikin M Am J Rhinol Allergy; 2010; 24(5):374-7. PubMed ID: 21244738 [TBL] [Abstract][Full Text] [Related]
10. Incubation periods of experimental rhinovirus infection and illness. Harris JM; Gwaltney JM Clin Infect Dis; 1996 Dec; 23(6):1287-90. PubMed ID: 8953073 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. Turner RB; Wecker MT; Pohl G; Witek TJ; McNally E; St George R; Winther B; Hayden FG JAMA; 1999 May; 281(19):1797-804. PubMed ID: 10340366 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human interferon-gamma as prophylaxis against rhinovirus colds in volunteers. Higgins PG; al-Nakib W; Barrow GI; Tyrrell DA J Interferon Res; 1988 Oct; 8(5):591-6. PubMed ID: 2853194 [TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds. Gwaltney JM; Park J; Paul RA; Edelman DA; O'Connor RR; Turner RB Clin Infect Dis; 1996 Apr; 22(4):656-62. PubMed ID: 8729205 [TBL] [Abstract][Full Text] [Related]
18. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Hayden FG; Turner RB; Gwaltney JM; Chi-Burris K; Gersten M; Hsyu P; Patick AK; Smith GJ; Zalman LS Antimicrob Agents Chemother; 2003 Dec; 47(12):3907-16. PubMed ID: 14638501 [TBL] [Abstract][Full Text] [Related]
19. Ipratropium nasal spray: a new treatment for rhinorrhea in the common cold. Borum P; Olsen L; Winther B; Mygind N Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):418-20. PubMed ID: 6452842 [TBL] [Abstract][Full Text] [Related]